Citius Pharmaceuticals Insider Trades
NASDAQ: CTXRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Citius Pharmaceuticals insider activity
No Citius Pharmaceuticals insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Holuka Eugene Myron (Director) reporting a transaction in 2,415 shares at $0.015 on Mar 13, 2024. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CTXR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CTXR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 13, 2024 | Holuka Eugene MyronDirector | Tax withholding | 48 | $36 | Form 4 |
| Mar 13, 2024 | Holuka Eugene MyronDirector | Option exercise | 2,415 | $36.23 | Form 4 |
| Mar 4, 2024 | Webb CarolDirector | Tax withholding | 236 | $180.78 | Form 4 |
| Mar 4, 2024 | Webb CarolDirector | Option exercise | 12,071 | $181.07 | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4